EORTC new drug development office coordinating and monitoring programme for phase I and II trials with new anticancer agents

G. Schwartsmann, J. Wanders, I. J. Koier, H. R. Franklin, O. Dalesio, H. W. Hornstra, M. van Glabbeke, J. Renard, A. T. Van Oosterom, S. B. Kaye, H. M. Pinedo

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1162-1168
Number of pages7
JournalEuropean Journal of Cancer and Clinical Oncology
Volume27
Issue number9
DOIs
StatePublished - 1991
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Schwartsmann, G., Wanders, J., Koier, I. J., Franklin, H. R., Dalesio, O., Hornstra, H. W., van Glabbeke, M., Renard, J., Van Oosterom, A. T., Kaye, S. B., & Pinedo, H. M. (1991). EORTC new drug development office coordinating and monitoring programme for phase I and II trials with new anticancer agents. European Journal of Cancer and Clinical Oncology, 27(9), 1162-1168. https://doi.org/10.1016/0277-5379(91)90317-7